Clear Perspectives Financial Planning, LLC Gilead Sciences, Inc. Transaction History
Clear Perspectives Financial Planning, LLC
- $178 Million
- Q1 2023
A detailed history of Clear Perspectives Financial Planning, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clear Perspectives Financial Planning, LLC holds 100 shares of GILD stock, worth $8,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$8,951
Previous $8,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
1,903Shares Held
1.02BCall Options Held
12MPut Options Held
9.02M-
Black Rock Inc. New York, NY121MShares$10.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.3 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.83 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.41 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.31 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $112B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...